TriSalus Life Sciences, Inc.TLSINASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank60
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-28.02M
↑ 13% vs avg
Percentile
P60
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-32.31M
Historical baseline
PeriodValueYoY Change
TTM$-28.02M+22.5%
2024$-36.16M+38.3%
2023$-58.65M-25.4%
2022$-46.76M-98.4%
2021$-23.57M-3213.0%
2020$-711386.00-